Strategic leadership Recent leadership change with Frank Balon as President and Chief Legal Officer suggests a potential shift in strategic priorities and governance. This can be a moment to engage on high-value contracts, private label partnerships, and long-term manufacturing commitments as the new leadership aligns operations with growth.

Expansion momentum Significant past and ongoing plant investments in Elma, New York indicate capacity growth and capability enhancements. Target opportunities include scaling aseptic low-acid product lines, scaling private label production, and securing more deep-dive co-manufacturing arrangements.

Financial foothold Recent financing activity and a revenue tier in the lower mid-market suggest openness to new credit-backed projects or joint ventures. Pitching flexible financing options for equipment upgrades, facility expansions, or multi-year contract manufacturing arrangements could be compelling.

Aseptic expertise Specialization in low-acid aseptic processing positions Steuben Foods as a partner for advanced beverage, dairy, or plant-based liquid products. Opportunities exist for private label programs, co-development of new aseptic formats, and regional distribution partnerships.

Small to mid-market fit Employee range and revenue signals align with mid-market clients seeking reliable contract manufacturing, private label, or branded production. Focus on mid-sized CPGs looking for scalable capacity, quick onboarding, and integrated quality controls to diversify their portfolio.